athersys inc (ATHX:NASDAQ CM)
Warren Sherman M.D., F.A.C.C,F.S.C.A.I
Scientific and Clinical Advisor,Athersys, Inc.
|Age||Total Calculated Compensation||This person is connected to 89 board members in 4 different organizations across 5 different industries.|
See Board Relationships
Dr. Warren Sherman, M.D., F.A.C.C, F.S.C.A.I has been the Chief Medical Officer of Celyad SA since November 1, 2014. Dr. Sherman is a renowned American interventional cardiologist with more than 30 years’ experience in the field of cardiology, with a focus in cell-based therapies for treating patients post myocardial infarction and with heart failure. Before joining Cardio3 BioSciences, Dr. Sherman was at the Columbia University Medical Center in New York, where he served ...
3201 Carnegie AvenuePhone: 216-431-9900
Cleveland, Ohio 44115
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
SUNY Upstate Medical University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.||Chief Executive Officer and Director|
Caladrius Biosciences, Inc.
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|Silviu Itescu MBBS (Hons), FRACP, FACP, FACR, FTSE||Founder, Chief Executive Officer, Managing Director, Chairman of Scientific Advisory Board, Executive Director and Member of Science and Technology Committee|
|A$1.8M||Compensation as of Fiscal Year 2014.|